Your browser doesn't support javascript.
loading
Nivolumab and anti-HCV activity, a case report.
Wuyts, Laura; Janssens, Annelies; Vonghia, Luisa; Michielsen, Peter; Raskin, Jo; Driessen, Ann; Van Hees, Stijn; Francque, Sven; Vanwolleghem, Thomas.
Afiliação
  • Wuyts L; Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, Belgium.
  • Janssens A; Department of Thoracic Oncology, Antwerp University Hospital (UZA), Antwerp, Belgium.
  • Vonghia L; Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, Belgium.
  • Michielsen P; Translational Sciences in Inflammation and Immunology (TWI2N), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
  • Raskin J; Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, Belgium.
  • Driessen A; Department of Thoracic Oncology, Antwerp University Hospital (UZA), Antwerp, Belgium.
  • Van Hees S; Department of Pathology, Antwerp University Hospital (UZA), Antwerp, Belgium.
  • Francque S; Department of Gastroenterology and Hepatology, Antwerp University Hospital (UZA), Antwerp, Belgium.
  • Vanwolleghem T; Translational Sciences in Inflammation and Immunology (TWI2N), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
Acta Clin Belg ; 76(5): 392-396, 2021 Oct.
Article em En | MEDLINE | ID: mdl-32182200

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Acta Clin Belg Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Acta Clin Belg Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica